PRO-Spectus Revenue and Competitors
Estimated Revenue & Valuation
- PRO-Spectus's estimated annual revenue is currently $20.8M per year.
- PRO-Spectus's estimated revenue per employee is $155,000
Employee Data
- PRO-Spectus has 134 Employees.
- PRO-Spectus grew their employee count by 23% last year.
PRO-Spectus's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | President and CEO | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | Chief Operating Officer | Reveal Email/Phone |
6 | Chief People & Culture Officer | Reveal Email/Phone |
7 | Chief Technology Officer | Reveal Email/Phone |
8 | VP, Business Development | Reveal Email/Phone |
9 | VP, Pharmacy & Clinical Solutions, Market Access | Reveal Email/Phone |
10 | VP, Market Access | Reveal Email/Phone |
PRO-Spectus Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is PRO-Spectus?
PRO-Spectus Inc. is a unique company whose primary business is conducted with clients in the pharmaceutical, medical device and diagnostic industries who develop novel products for treatments across a wide variety of patient populations. Our team members apply their experience with patient-reported outcomes, epidemiology, health economics, market access and reimbursement in creative ways to maximize product success. Please see our company's website for more information or drop me a note.
keywords:N/AN/A
Total Funding
134
Number of Employees
$20.8M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PRO-Spectus News
The Company has prepared a prospectus in connection with the listing of the shares on Euronext Expand and the contemplated subsequent transfer...
SHAMARAN PUBLISHES SUPPLEMENT TO PROSPECTUS. Tue, April 26, 2022, 2:30 p.m. ·5 min read. In this article: SHASF. /NOT FOR RELEASE, DISTRIBUTION OR...
Proposed Changes. Changes to prospectus requirement for admission to trade on a U.K. regulated market. The proposed new regime will not change...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $20.8M | 134 | 10% | $43.8M |
#2 | $36.2M | 134 | 7% | N/A |
#3 | $41.3M | 134 | 22% | N/A |
#4 | $25.3M | 134 | 12% | $69M |
#5 | $44.2M | 134 | -3% | N/A |